deltatrials
Recruiting PHASE2 INTERVENTIONAL 32-arm NCT03899155

Pan Tumor Rollover Study

Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

Sponsor: Bristol-Myers Squibb

Conditions Cancer
Interventions Bevacizumab Cabozantinib Capecitabine Daratumumab Enzalutamide Fluorouracil Ipilimumab Leucovorin Nivolumab Nivolumab + Relatlimab Oxaliplatin Pembrolizumab Pemetrexed Regorafinib Relatlimab Rucaparib Sunitinib Temozolomide Trametinib
Updated 61 times since 2019 Last updated: Mar 2, 2026 Started: May 5, 2020 Primary completion: Aug 25, 2029 Completion: Aug 25, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cancer, this trial is actively recruiting participants. The trial is conducted by Bristol-Myers Squibb and has accumulated 61 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Oct 2022 · 30 days · monthly snapshot~Oct 2022 – ~Nov 2022 · 31 days · monthly snapshot~Nov 2022 – ~May 2023 · 6 months · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~May 2024 · 2 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~Feb 2025 · 2 months · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Aug 2025 · 31 days · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Nov 2025 · 31 days · monthly snapshot~Nov 2025 – ~Dec 2025 · 30 days · monthly snapshot~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshot~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshot~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

61 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE2

  2. Feb 2026 — Mar 2026 [monthly]

    Recruiting PHASE2

  3. Jan 2026 — Feb 2026 [monthly]

    Recruiting PHASE2

  4. Dec 2025 — Jan 2026 [monthly]

    Recruiting PHASE2

  5. Nov 2025 — Dec 2025 [monthly]

    Recruiting PHASE2

▶ Show 56 earlier versions

  1. Oct 2025 — Nov 2025 [monthly]

    Recruiting PHASE2

  2. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE2

  3. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2025 — Aug 2025 [monthly]

    Recruiting PHASE2

  5. Jun 2025 — Jul 2025 [monthly]

    Recruiting PHASE2

  6. May 2025 — Jun 2025 [monthly]

    Recruiting PHASE2

  7. Apr 2025 — May 2025 [monthly]

    Recruiting PHASE2

  8. Mar 2025 — Apr 2025 [monthly]

    Recruiting PHASE2

  9. Feb 2025 — Mar 2025 [monthly]

    Recruiting PHASE2

  10. Dec 2024 — Feb 2025 [monthly]

    Recruiting PHASE2

  11. Nov 2024 — Dec 2024 [monthly]

    Recruiting PHASE2

  12. Oct 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  13. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  14. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  15. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE2

  16. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  17. May 2024 — Jun 2024 [monthly]

    Recruiting PHASE2

  18. Mar 2024 — May 2024 [monthly]

    Recruiting PHASE2

  19. Feb 2024 — Mar 2024 [monthly]

    Recruiting PHASE2

  20. Jan 2024 — Feb 2024 [monthly]

    Recruiting PHASE2

  21. Nov 2023 — Jan 2024 [monthly]

    Recruiting PHASE2

  22. Oct 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  23. Sep 2023 — Oct 2023 [monthly]

    Recruiting PHASE2

  24. Aug 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

  25. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE2

  26. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE2

  27. May 2023 — Jun 2023 [monthly]

    Recruiting PHASE2

  28. Nov 2022 — May 2023 [monthly]

    Recruiting PHASE2

  29. Oct 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  30. Sep 2022 — Oct 2022 [monthly]

    Recruiting PHASE2

  31. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  32. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  33. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  34. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  35. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  36. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  37. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE2

  38. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  39. Oct 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  40. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  41. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  42. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  43. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  44. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  45. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  46. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  47. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE2

  48. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  49. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

  50. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE2

  51. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

  52. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE2

  53. Nov 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

    Phase: PHASE4 → PHASE2

  54. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  55. Aug 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE4

  56. May 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bristol-Myers Squibb
  • Clovis Oncology, Inc.
  • Exelixis
  • Janssen Pharmaceuticals
  • Novartis
Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Aachen, Germany , Adachi-Ku, Japan , Adelaide, Australia , Albuquerque, United States , Alicante, Spain , Allentown, United States , Amsterdam, Netherlands , Ankara, Turkey (Türkiye) , Ann Arbor, United States and 271 more locations